Looking at the limited evidence from other studies on cannabinoid effects on SOD1G93 A transgenic mice, THC and the synthetic CB1/CB2 agonist WIN55,212–2 (WIN) delayed disease progression although WIN-treatment did not affect the life span of ALS transgenic mice (Bilsland et al. 2006; Raman et al. 2004). The gene discussed is CNR2; the disease is amyotrophic lateral sclerosis.